Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Hexacetonide vs Betamethasone on IOP in Knee OA
NCT07242846Phase 4Completed
- Sponsor
- Niğde Ömer Halisdemir University
- Start
- Oct 2025
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of betamethasone, triamcinolone hexacetonide in knee osteoarthritis (OA), sponsored by Niğde Ömer Halisdemir University. Started Oct 2025; status: completed.
02
Drugs
betamethasonetriamcinolone hexacetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07242846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242846.